Researcher develops method to identify women who will benefit from tamoxifen therapy

[News]

Innovative research by Rene Bernards, Ph.D., the co-founder of Agendia, Inc., has identified a gene signature that has potential to identify which patients will benefit from tamoxifen therapy.

More... (http://www.medicalnewstoday.com/releases/280498.php)